Contract development and manufacturing organisation in Cramlington, UK, serving pharmaceutical and biotech companies.
Founded in 1969 and headquartered in Cramlington, UK, Sterling Pharma Solutions Limited is a contract development and manufacturing organisation for the pharmaceutical and biotech sectors. Its services include high potency active pharmaceutical ingredients, hazardous chemistry, controlled substances, peptides and advanced drug conjugates. In fiscal year 2023 the company reported revenue of USD 157.24 mn and EBITDA of USD 41.69 mn. In May 2023 a consortium co-led by AlpInvest Partners and Pantheon acquired the company, alongside Partners Group and GHO Capital; terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in